Chi-Med Announces the Exercise of Underwriters’ Over-allotment Option for Public Offering of ADSs Feb 6, 2020 02:58AM
Chi-Med Announces the Exercise of Underwriters’ Over-allotment Option for Public Offering of ADSs Feb 6, 2020 02:58AM
Hutchison China MediTech (HCM) Prices 4.4M ADS Offering at $25/ADS Jan 23, 2020 05:54AM
Chi-Med Announces Pricing of US$110 Million Public Offering of ADSs Jan 23, 2020 03:06AM
Chi-Med Announces the Closing of U.S. Public Offering of American Depositary Shares (ADSs) Raising Approximately US$301.3 Million on the Nasdaq Global Select Market Oct 30, 2017 11:45AM


Oct 27, 2017 07:26AM Chi-Med Announces the Full Exercise of Underwriters' Over-allotment Option
Oct 26, 2017 06:25AM Hutchison China MediTech (HCM) Prices 9.886M ADS at $26.50/Sh
Oct 25, 2017 11:56PM Chi-Med Announces Pricing of U.S. Public Offering of ADSs Raising US$262 Million on Nasdaq Global Select Market
Oct 24, 2017 04:33PM Hutchison China MediTech (HCM) Plans $262M Offer of ADSs
Oct 24, 2017 04:31PM Chi-Med Announces Proposed Offering of ADSs
Apr 13, 2016 11:55AM Hutchison China MediTech Limited Announces Exercise of Overallotment Option
Mar 22, 2016 10:30AM Hutchison China MediTech Limited Announces Closing of U.S. Public Offering of ADSs Raising Approximately US$101 Million on the Nasdaq Stock Market
Mar 16, 2016 11:35PM Hutchison China MediTech Limited Announces Pricing of U.S. Public Offering of ADSs
Mar 16, 2016 11:35PM Hutchison China MediTech Limited Announces Pricing of U.S. Public Offering of ADSs
Mar 4, 2016 01:13PM Hutchison China MediTech Limited Announces Launch of Potential U.S. Public Offering of ADSs